Bovine serum albumin (BSA) is a significant plasma protein, representing approximately 60% of the plasma protein content, and it carries and transports numerous physiological and non-physiological ligands. It contains 17 disulfide bonds and one free cysteine residue (Cys34), which is instrumental in dimerization and affects higher-order associations, as evident by the reduced rate of aggregation when Cys34 is covalently attached to other compounds. The MTT assay shows that BSA is conducive to cell growth regardless of its state of aggregation, and the absence of cytotoxicity is corroborated by membrane permeabilization assays. Over a period of 40 hours, cell viability increases by 300-400% in cells treated with BSA, signifying that BSA-treated cells surpass the viability of untreated cells^[1].